News
With support from the National Institutes of Health, a University of Texas at Arlington bioengineering professor is ...
A study led by scientists at King's has revealed how the physical orientation of the heart inside the chest dramatically ...
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.
Patients with abnormal findings had worse outcomes down the road. Still unknown is exactly how to modify that risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results